(IBHJ) Trust - iBonds 2030 Term - Overview
Etf: High Yield Corporate Bonds, Fixed Income Securities, Index Tracking
Dividends
| Dividend Yield | 7.27% |
| Yield on Cost 5y | 8.48% |
| Yield CAGR 5y | 36.35% |
| Payout Consistency | 98.5% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 3.82% |
| Relative Tail Risk | -1.50% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.60 |
| Alpha | 1.19 |
| Character TTM | |
|---|---|
| Beta | 0.207 |
| Beta Downside | 0.092 |
| Drawdowns 3y | |
|---|---|
| Max DD | 4.93% |
| CAGR/Max DD | 2.02 |
Description: IBHJ Trust - iBonds 2030 Term January 05, 2026
The iShares iBonds 2030 Term High Yield and Income ETF (BATS: IBHJ) is a U.S.-based target-maturity fund that seeks to track its underlying index by allocating at least 80 % of assets to the index’s component securities and at least 90 % to fixed-income instruments that the manager believes will best replicate index performance. Because the fund is classified as non-diversified, it may hold a relatively concentrated portfolio of high-yield bonds maturing around 2030.
Key metrics as of the latest reporting period include an expense ratio of 0.45 %, a weighted-average maturity of approximately 9.5 years, and a distribution yield near 7.2 % (annualized). The fund’s credit exposure is heavily weighted toward BB-rated issuers, reflecting the broader high-yield market, which is sensitive to changes in the U.S. Treasury curve and corporate default rates. Current macro drivers-namely the Federal Reserve’s policy stance on interest rates and the health of the U.S. labor market-directly influence the spread compression or widening that will affect IBHJ’s total return.
If you want a more granular, data-driven assessment of IBHJ’s risk-adjusted performance, consider reviewing the analytics available on ValueRay.
What is the price of IBHJ shares?
Over the past week, the price has changed by +0.14%, over one month by +0.40%, over three months by +2.53% and over the past year by +7.90%.
Is IBHJ a buy, sell or hold?
What are the forecasts/targets for the IBHJ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 30.6 | 14.6% |
IBHJ Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 113.2m USD (113.2m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 113.2m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 113.2m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.68% (E(113.2m)/V(113.2m) * Re(6.68%) + (debt-free company))
Discount Rate = 6.68% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)